I disagree…I looked further into it…
check this site out:
Here is the main points I want to point out(both degenerative):
Case Study No. 2: A ten year old cat weighing ten pounds presented symptoms of a slight limp in hind right leg and refusal to jump onto couch or bed as previously displayed. Veterinarian palpation revealed pain in hind hip and stifle joint. Preliminary diagnosis being degenerative joint disease.
A regiment of the present invention was introduced including 70 mg. MSM,
40mg. chondroitin sulfate, 40mg. glucosamine potassium, 40mg.
glucosamine hydrochloride, 40mg. glucosamine sodium,lOmg. N-Acetyl
D-Glucosamine,10mg. sodium ascorbate, 3mg. manganese proteinate.
Divided into two doses administered paternally with cat food morning and
evening. Within 7 days of initial administration symptoms of a limp had
vanished, gait had returned to normal. Within 21 days of initial
administration the behavior of jumping on couches and beds had returned.
Cat remained on present invention for 60 days when administration was
halted. After 120 days of initial administratin, no prior symptoms of DJD
were detectable. Alleviation of symptoms and longetivity of relief
attributed to use of present invention.
Case Study No. 3: An 18 year old thoroughbred retired after racing career.
Currently a broodmare weighing approximately 1200 lbs. diagnosed by veterinarian with ring bone in hind pastern and degenerative joint disease in knees displayed tactile symptoms of heat and inflammation, while exhibiting difficulty walking and trotting. Was placed on a regiment of the present invention after aborting pregnancy due to increased load bearing stress. While pregnant, this mare's symptoms worsened in direct relation to the growth of foal. By the5th month of pregnancy, injections ofADAQUANO (an intravenous GAG) were administered; mild symptomatic relief was evident but short lived. By the7"month she was unable to walk and refused to eat, resulting in stress related abortion of the foal.
Subsequently the mare was examined and no uterine abnormalities were detected. The current invention was introduced paternally including 4g.
MSM, 2.4g. glucosamine potassium, 2.4g. chondroitin sulfate 2.4g. glucosamine hydrochloride, 2.4g. glucosamine sulfate, 0.6g. N-Acetyl
D-Glucosamine, 0.6g. sodium ascorbate, 0.2g. manganese proteinate. Three
months prior to breeding and remained on this regiment through foaling.
After twenty days of initial administration outward signs of discomfort
walking and trotting had subsided. After forty days of initial administration,
tactile symptoms of heat and inflammation in the joint areas had dissipated
as well. The mare remained on the present invention through foaling
without reoccurrence of symptoms. The mare currently remains on the
same regiment. The introduction of the present invention into the diet of
this mare was directly responsible for increased mobility, pain management,
and joint reparation.
Case #4 also looks helpful…